Literature DB >> 25845477

No cardiomyopathy in X-linked myopathy with excessive autophagy.

Antti Saraste1, Juha W Koskenvuo2, Juhani Airaksinen3, Nivetha Ramachandran4, Iulia Munteanu4, Bjarne Udd5, Sanna Huovinen6, Hannu Kalimo7, Berge A Minassian4.   

Abstract

In X-linked myopathy with excessive autophagy (XMEA) progressive sarcoplasmic accumulation of autolysosomes filled with undegraded debris leads to atrophy and weakness of skeletal muscles. XMEA is caused by compromised acidification of lysosomes resulting from hypofunction of the proton pump vacuolar ATPase (V-ATPase), due to hypomorphic mutations in VMA21, whose protein product assembles V-ATPase. To what extent the cardiac muscle is affected is unknown. Therefore we performed a comprehensive cardiac evaluation in four male XMEA patients, and also examined pathology of one deceased patient's cardiac and skeletal muscle. None of the symptomatic men (aged 25-48 years) had history or symptoms of cardiomyopathy. Resting electrocardiograms and echocardiographies were normal. MRI showed normal left ventricle ejection fraction and myocardial mass. Myocardial late-gadolinium enhancement was not detected. The deceased patient's skeletal but not cardiac muscle showed characteristic accumulation of autophagic vacuoles. In conclusion, in classic XMEA the myocardium is structurally, electrically and clinically spared.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autolysosomes; Cardiomyopathy; Danon disease; Electron microscopy; Organellar acidification; X-linked myopathy with excessive autophagy

Mesh:

Substances:

Year:  2015        PMID: 25845477     DOI: 10.1016/j.nmd.2015.03.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

Review 1.  "Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders.

Authors:  Perrine Castets; Stephan Frank; Michael Sinnreich; Markus A Rüegg
Journal:  J Neuromuscul Dis       Date:  2016-05-27

2.  The role of autophagy in advanced glycation end product-induced proliferation and migration in rat vascular smooth muscle cells.

Authors:  Zhigang Liu; Shuwei Huang; Pengfei Hu; Hui Zhou
Journal:  Iran J Basic Med Sci       Date:  2018-06       Impact factor: 2.699

Review 3.  The Role of Autophagy in Skeletal Muscle Diseases.

Authors:  Qianghua Xia; Xubo Huang; Jieru Huang; Yongfeng Zheng; Michael E March; Jin Li; Yongjie Wei
Journal:  Front Physiol       Date:  2021-03-25       Impact factor: 4.566

4.  Altered in vitro muscle differentiation in X-linked myopathy with excessive autophagy.

Authors:  Stephanie A Fernandes; Camila F Almeida; Lucas S Souza; Monize Lazar; Paula Onofre-Oliveira; Guilherme L Yamamoto; Letícia Nogueira; Letícia Y Tasaki; Rafaela R Cardoso; Rita C M Pavanello; Helga C A Silva; Merari F R Ferrari; Anne Bigot; Vincent Mouly; Mariz Vainzof
Journal:  Dis Model Mech       Date:  2020-01-10       Impact factor: 5.758

Review 5.  Machinery, regulation and pathophysiological implications of autophagosome maturation.

Authors:  Yan G Zhao; Patrice Codogno; Hong Zhang
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-23       Impact factor: 94.444

6.  Mutations in the V-ATPase Assembly Factor VMA21 Cause a Congenital Disorder of Glycosylation With Autophagic Liver Disease.

Authors:  Magda Cannata Serio; Laurie A Graham; Angel Ashikov; Tom H Stevens; Matias Simons; Dirk J Lefeber; Lars Elmann Larsen; Kimiyo Raymond; Sharita Timal; Gwenn Le Meur; Margret Ryan; Elzbieta Czarnowska; Jos C Jansen; Miao He; Can Ficicioglu; Pavel Pichurin; Linda Hasadsri; Berge Minassian; Alessandra Rugierri; Hannu Kalimo; W Alfredo Ríos-Ocampo; Christian Gilissen; Richard Rodenburg; Johan W Jonker; Adriaan G Holleboom; Eva Morava; Joris A Veltman; Piotr Socha
Journal:  Hepatology       Date:  2020-12       Impact factor: 17.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.